Siemens AG Acquires Dotmatics for $5.1 Billion to Expand Digital Twin Technology and AI-Powered Software in Life Sciences R&D

Siemens AG has announced the acquisition of Dotmatics, a prominent Life Sciences R&D software provider based in Boston, for $5.1 billion from Insight Partners. The acquisition aims to bolster Siemens' position in the Life Sciences sector by integrating Dotmatics' market-leading platform and profitable scientific applications into Siemens Xcelerator.

The acquisition is projected to expand Siemens' industrial software market by $11 billion, driven by the increasing need for medication, advancements in science, and enhanced collaboration across value chains. It will enable Siemens to tap into the lucrative Life Sciences software market and accelerate customer innovation, aligning with the company's strategic goals.

Additionally, the acquisition is expected to generate more than $300 million in revenue in fiscal year 2025, with substantial revenue synergies projected in the medium to long term. The transaction is anticipated to close in the first half of fiscal year 2026, subject to customary closing conditions and regulatory approvals.

Dotmatics, with its enterprise R&D platform and global presence, is dedicated to driving efficiency and innovation in the scientific community. Siemens AG, a prominent technology company, is focused on leveraging digital transformation and sustainability to empower various industries. The acquisition of Dotmatics signifies Siemens' commitment to strategic growth fields, particularly in software, AI-enabled products, and sustainability, positioning the company for enhanced performance and value creation.

Learn more about the acquisition here.